| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2011.05.072 |
| P698 | PubMed publication ID | 21651945 |
| P50 | author | Carlos Gamazo | Q56995564 |
| Ibai Tamayo | Q57981788 | ||
| Juan José Lasarte | Q40687778 | ||
| Juan M. Irache | Q43161954 | ||
| P2093 | author name string | C Mansilla | |
| J de Souza | |||
| A I Camacho | |||
| I Esparza | |||
| R Da Costa Martins | |||
| P2860 | cites work | Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. | Q53670466 |
| Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens | Q57216501 | ||
| In vitro evaluation of gentamicin released from microparticles | Q74604522 | ||
| Toll-free vaccines? | Q79897713 | ||
| Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do | Q80625739 | ||
| Exploiting lymphatic transport and complement activation in nanoparticle vaccines | Q81305052 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults. | Q30379899 | ||
| Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice. | Q33282108 | ||
| Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling | Q33705184 | ||
| Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. | Q34324135 | ||
| GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives | Q34655188 | ||
| Schistosome larvae stimulate macrophage cytokine production through TLR4-dependent and -independent pathways. | Q35946159 | ||
| The role of complement in biomaterial-induced inflammation | Q36564335 | ||
| T-cell regulation: with complements from innate immunity | Q36684909 | ||
| Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome | Q37070610 | ||
| Immunomodulatory biomaterials | Q37228960 | ||
| Delivery systems: a vaccine strategy for overcoming mucosal tolerance? | Q37354182 | ||
| Properdin: emerging roles of a pattern-recognition molecule. | Q37641361 | ||
| Crosstalk pathways between Toll-like receptors and the complement system | Q37691806 | ||
| Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers | Q40721665 | ||
| Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation | Q42117985 | ||
| The covalent-binding reaction of complement component C3 | Q42876404 | ||
| Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles | Q43466579 | ||
| The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig. | Q43543148 | ||
| Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. | Q43603350 | ||
| Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates | Q44185143 | ||
| Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties | Q44403429 | ||
| Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery | Q44985757 | ||
| TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses | Q44997831 | ||
| Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. | Q45962430 | ||
| Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles. | Q45985497 | ||
| Salmonella-like bioadhesive nanoparticles | Q46560166 | ||
| Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism | Q46848409 | ||
| Synthesis of beta-(1-->4)-oligo-D-mannuronic acid neoglycolipids | Q46898321 | ||
| Development of a novel vaccine delivery system based on Gantrez nanoparticles. | Q51117082 | ||
| P433 | issue | 41 | |
| P304 | page(s) | 7130-7135 | |
| P577 | publication date | 2011-06-07 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators | |
| P478 | volume | 29 |
| Q39151158 | Adjuvants for allergy immunotherapeutics. |
| Q36591050 | Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases |
| Q47685899 | Effects of engineered nanoparticles on the innate immune system |
| Q34057755 | Immunogenicity of peanut proteins containing poly(anhydride) nanoparticles |
| Q27021145 | Immunomodulation of nanoparticles in nanomedicine applications |
| Q46246924 | Maternal Vaccination. Immunization of Sows during Pregnancy against ETEC Infections |
| Q97883512 | Mechanisms of Particles in Sensitization, Effector Function and Therapy of Allergic Disease |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q26825418 | Nanoparticulate adjuvants and delivery systems for allergen immunotherapy |
| Q38102471 | Nanovaccines and their mode of action. |
| Q39627292 | Porous Silicon and Polymer Nanocomposites for Delivery of Peptide Nucleic Acids as Anti-MicroRNA Therapies |
| Q38256081 | Prolonged hypocalcemic effect by pulmonary delivery of calcitonin loaded poly(methyl vinyl ether maleic acid) bioadhesive nanoparticles |
| Q27027780 | Stimulating antitumor immunity with nanoparticles |
| Q59798948 | Surface engineered polyanhydride-based oral Salmonella subunit nanovaccine for poultry |
Search more.